Politics Of Mega-Mergers: Health Reform And U.S. Biopharma Realignment

One theme tying together the two mega-mergers announced so far in 2009 is the sense that biopharma companies are taking defensive measures to prepare for health care reform in the U.S

More from Archive

More from Pink Sheet